Modulation of α-synuclein AGE-based cytotoxic aggregation by zinc oxide nanoparticles: a potential therapeutic approach
Schematic depicting the fate of α-synuclein (αS) monomers (a) under the PD pathophysiological conditions (b) in the presence of glycating agents, like MGO, and (c) in the presence of MGO and ZnONP interacting interfaces.
Authors
- Dojalisa Sahu (ORCID: https://orcid.org/0000-0002-4552-3740)
- Suman Jha (ORCID: https://orcid.org/0000-0003-3139-7621)
- Sonali Mohanty (ORCID: https://orcid.org/0000-0001-6450-0694)
Institutions
- National Institute of Technology Rourkela (IN)
- National Institute of Mental Health and Neurosciences (IN)
Publication Details
- Journal
- New Journal of Chemistry
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1039/d5nj03165f
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00